Mutations in the human autophagy gene EPG5 cause the multisystem disorder Vici syndrome. Here we demonstrated that EPG5 is a Rab7 effector that determines the fusion specificity of autophagosomes with late endosomes/lysosomes. EPG5 is recruited to late endosomes/lysosomes by direct interaction with Rab7 and the late endosomal/lysosomal R-SNARE VAMP7/8. EPG5 also binds to LC3/LGG-1 (mammalian and C. elegans Atg8 homolog, respectively) and to assembled STX17-SNAP29 Qabc SNARE complexes on autophagosomes. EPG5 stabilizes and facilitates the assembly of STX17-SNAP29-VAMP7/8 trans-SNARE complexes, and promotes STX17-SNAP29-VAMP7-mediated fusion of reconstituted proteoliposomes. Loss of EPG5 activity causes abnormal fusion of autophagosomes with various endocytic vesicles, in part due to elevated assembly of STX17-SNAP25-VAMP8 complexes. SNAP25 knockdown partially suppresses the autophagy defect caused by EPG5 depletion. Our study reveals that EPG5 is a Rab7 effector involved in autophagosome maturation, providing insight into the molecular mechanism underlying Vici syndrome.
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In Brief
Wang et al. demonstrate that the Vici syndrome protein EPG5 acts as a tethering factor that determines the fusion specificity of autophagosomes with late endosomes/lysosomes. EPG5 stabilizes and facilitates assembly of the trans-SNARE complex that mediates autophagosome maturation.
INTRODUCTION
Membrane-enclosed organelles are intricately connected via vesicle-mediated membrane trafficking (Bonifacino and Glick, 2004) . The specificity and efficiency of membrane trafficking depends on the concerted action of Rab GTPases, tethers, and the SNARE complex (Cai et al., 2007; Wickner and Schekman, 2008) . Different Rab GTPases associate with distinct membrane organelles (Stenmark, 2009; Mizuno-Yamasaki et al., 2012) . For example, Rab5 presents on early endosomes, while Rab7 locates on late endosomes. Tethering factors, which are generally recruited to cognate membranes by Rab GTPases, function in the initial attachment of transport vesicles to their target membranes for fusion (Brö cker et al., 2010; Yu and Hughson, 2010) . The tethering factor p115 is essential for fusion of COPII vesicles with the Golgi apparatus, while the multisubunit HOPS tethering complex is required for several fusion events in late endosomes and the vacuole (Brö cker et al., 2010; Yu and Hughson, 2010) . The membrane fusion process is driven by trans-assembly of cognate sets of membrane-anchored SNARE proteins on the vesicle and target membranes. The core SNARE complex, consisting of a bundle of four a helices, is formed by the $60-residue SNARE motif in each SNARE protein (Jahn and Scheller, 2006; Sü dhof and Rothman, 2009 ). The assembly of cognate SNARE complexes under physiological conditions is facilitated by tethering factors (Cai et al., 2007; Yu and Hughson, 2010) .
Autophagy is an evolutionarily conserved lysosome-mediated degradation process (Nakatogawa et al., 2009; Feng et al., 2014) . It involves the formation of a crescent-shaped phagophore (also known as the isolation membrane, IM), which expands and closes to form the double-membrane autophagosome. The autophagosome is then delivered to the lysosomes/vacuole for degradation of the sequestrated materials. Genetic screens in yeast and worm have identified a group of autophagy proteins that act at distinct steps of autophagosome formation (Feng et al., 2014; Lu et al., 2013) . The Atg1/Atg13 Ser/Thr kinase complex and the Vps34/Atg14 PI(3)P kinase complex are involved in the induction and initiation of the IM (Nakatogawa et al., 2009; Feng et al., 2014) . The ubiquitin-like protein Atg8, which is conjugated to phosphatidylethanolamine (PE), associates with outer and inner membranes of autophagic structures (Nakatogawa et al., 2009; Feng et al., 2014) . The membrane-associated Atg8-PE interacts with a variety of factors at multiple steps in the autophagy pathway (Birgisdottir et al., 2013; McEwan et al., 2015) . . epg-5 mutants have enlarged vesicles (arrows), which are visible in L1 larvae and are most abundant in L4 larvae. Small granules (arrowheads) in WT intestine are lysosome-related organelles (LROs) or lipid droplets (LDs). epg-5 mutant larvae still contain LROs and LDs, which are visible in other focal planes. (E-L) Enlarged vesicles (arrows) in epg-5 mutants are labeled by GFP::LGG-1 (E and F), 23 FYVE::GFP (G and H), RFP::RME-1 (I and J), and LAAT-1::GFP (K and L). epg-5 mutants carrying an RFP::RME-1 transgene have fewer enlarged vesicles (I and J). (E)-(L) are confocal images. (M-P) Localization of GFP::LGG-1 and Cherry::RAB-7 (M and N) and RFP::RME-1 (O and P) in WT and epg-5 mutant intestine. WT intestine contains a few small GFP::LGG-1 puncta that are distinct from Cherry::RAB-7 (M) or RFP::RME-1 (O) puncta. In epg-5 mutant intestine, GFP::LGG-1 puncta accumulate and partially co-localize with enlarged Cherry::RAB-7 (N) or RFP::RME-1(P) punctate structures. The focal planes in (N) and (P) are different from those in (C), (E), (G), and (K). Vacuoles are not evenly distributed in epg-5 mutant intestine. GFP::LGG-1 puncta are evident on focal planes with fewer vacuoles. (Q and R) In control cells, GFP-Rab5 puncta are distinct from LC3 puncta, detected by anti-LC3 (Q). In hEPG5 KD cells, enlarged GFP-Rab5 punctate structures partially co-localize or closely associate with LC3 puncta (R). (S and T) In control cells, EHD1-GFP labels tubular structures and also forms a few puncta (S). In hEPG5 KD cells, EHD1-GFP forms many more punctate structures that partially co-localize with LC3 puncta (T). (M)-(T) are confocal fluorescent images. (U and V) Efficiency of hEPG5 siRNA KD. hEPG5 protein (U) and mRNA (V) levels are dramatically reduced in hEPG5 shRNA cells. The mRNA level, analyzed by real-time PCR, was normalized to that in control cells, which was set to 100. Data are shown as mean ± SEM (n = 3 independent experiments). *p < 0.05.
(legend continued on next page)
In higher eukaryotes, nascent autophagosomes fuse with endocytic vesicles to form amphisomes that further fuse with lysosomes to produce degradative autolysosomes, a process known as autophagosome maturation (Lamb et al., 2013) . Fusion of autophagosomes with late endosomes/lysosomes is mediated by a SNARE complex consisting of Syntaxin 17 (Qa SNARE) on autophagosomes, SNAP29 (Qbc SNARE), and the endosomal/lysosomal R-SNARE VAMP7/8 (Itakura et al., 2012) . This fusion process is regulated by several factors, including the late endosomal/lysosomal-localized protein PLEKHM1 (which directly interacts with LC3 [mammalian Atg8 homolog], HOPS, and Rab7) and TECPR1 (which interacts with PtdIns(3)P and the Atg12-Atg5 conjugate) (McEwan et al., 2015; Chen et al., 2012) . The HOPS complex (which is recruited to autophagosomes by Syntaxin 17) and the autophagosomal protein ATG14 (which interacts with STX17 and the STX17-SNAP29 Qabc complex) also regulate autophagosome maturation (Jiang et al., 2014; Diao et al., 2015) . The role of these factors in autophagosome maturation under physiological conditions, however, has not been demonstrated. Autophagy is intimately integrated with intracellular trafficking (Lamb et al., 2013) . Impairment of early or late endosome function results in accumulation of non-degradative autolysosomes (Lamb et al., 2013; Eskelinen, 2005) . The mechanisms that coordinate endocytic and autophagic processes are largely unknown.
The metazoan-specific autophagy gene EPG5 was identified by genetic screens in C. elegans. Loss of epg-5 function in worms causes defective autophagic degradation of a variety of protein aggregates during development (Tian et al., 2010) . Unlike other genetically identified ATG and EPG genes, which act during autophagosome formation, EPG5 deficiency in C. elegans, mice, and human blocks the maturation of autophagosomes into degradative autolysosomes (Tian et al., 2010; Zhao et al., 2013a) . Loss of Epg5 activity also impairs endosomal trafficking (Zhao et al., 2013a) . Epg5 knockdown (KD) slows endocytic degradation and delays endocytic recycling (Zhao et al., 2013a) . Recent studies revealed that human EPG5 mutations cause the multisystem disorder Vici syndrome (Cullup et al., 2013) . The molecular role of EPG5 in autophagy and endocytic trafficking remains unknown. Here we demonstrated that EPG5 directly interacts with Rab7 and VAMP7/8 on late endosomes/lysosomes, and also binds to LC3/LGG-1 (C. elegans Atg8 homolog) and the assembled STX17-SNAP29 Qabc complex on autophagosomes. EPG5 regulates the stability and the assembly of STX17-SNAP29-VAMP8 trans-SNARE complexes. Loss of function of EPG5 causes non-specific fusion of autophagosomes with other endocytic vesicles, resulting in formation of nondegradative enlarged vesicles. Our results demonstrate that EPG5 promotes specific fusion of autophagosomes with late endosomes/lysosomes.
RESULTS
In epg-5 Mutant Worms, Autophagosomes Fuse Abnormally with Endocytic Vesicles In contrast to wild-type (WT) and animals with mutations in genes acting during autophagosome formation, epg-5 mutants accumulated numerous enlarged vesicular structures in the intestine, as judged by differential interference contrast (DIC) microscopy ( Figures 1A-1D , S1A, and S1B, available online). The number of enlarged vesicles increased as development proceeded and peaked at the L4 larval stage ( Figure S1A ). The enlarged vesicles in epg-5 mutants were labeled by markers for autophagosomes (GFP::LGG-1), early endosomes (GFP::RAB-5 and 2xFYVE::GFP), late endosomes (GFP::RAB-7), and recycling endosomes (RFP::RME-1, an EH-domain-containing ATPase associated with recycling endosomes) ( Figures  1E-1J , S1C, and S1D). The lysosomal membrane protein LAAT-1::GFP labeled the vesicles ( Figures 1K and 1L ), while NUC-1::Cherry (lysosomal-localized DNaseII homolog) was detected inside the vesicles ( Figure S1E ). The enlarged vesicles, however, could not be stained by lysotracker ( Figure S1F ), suggesting that they are not acidic. RME-1-labeled recycling endosomes showed both tubular and spherical structures in WT intestinal cells, while epg-5 mutants contained fewer tubular and more spherical RME-1-labeled structures (Figures S1G and S1H). In WT intestine, RFP::RAB-5-, Cherry::RAB-7-, and RFP::RME-1-labeled structures were separable from a few small GFP::LGG-1 puncta ( Figures 1M, 1O , 1W, and S1I). As well as labeling enlarged vesicular structures, several endosome markers formed enlarged punctate structures in epg-5 mutant intestine. GFP::LGG-1 puncta dramatically accumulated and partially colocalized with the enlarged punctate structures labeled by reporters for RAB-5, RAB-7, RME-1, and NUC-1 in epg-5 mutants ( Figures 1N, 1P , 1W, and S1J-S1L) (we define two puncta as colocalized if their fluorescent signals overlap by >70%, and as associated if their fluorescent signals are in close proximity but with a limited overlap). BFP::LGG-1 puncta were labeled by both RFP::RME-1 and LAAT-1::GFP ( Figures S1M and S1N ). These results indicate that autophagosomes and various endosomes coalesce in epg-5 mutant intestine, and EPG-5 may determine the fusion specificity of maturing autophagosomes.
TECPR1 and PLEKHM1 participate in autophagosome maturation in mammalian cells (Chen et al., 2012; McEwan et al., 2015) . We examined whether their C. elegans homologs are involved in autophagy. Putative null mutants of t01h3.2 and y51h1a.2, encoding TECPR1 and PLEKHM1, respectively, were created using CRISPR/Cas9. In t01h3.2(bp1286) and y51h1a.2(bp1287) mutants, there was no accumulation of SQST-1 aggregates or LGG-1 puncta in embryos or larvae (Figures LGG-1 puncta varies among animals. Puncta R1 mm in diameter were examined in five different animals.) (X) Quantification of co-localization of indicated markers with LC3 puncta in control and hEPG5 KD cells. Data are shown as mean ± SEM in (W) and (X). *p < 0.05, **p < 0.01, ***p < 0.001. Data were compared with two-tailed unpaired Student's t tests. Scale bars, 10, 5 (inserts in M-P), and 2 mm (inserts in Q-T Figures  1Q, 1X , and S1P). In hEPG5 KD cells, LC3 puncta were enlarged and more abundant even under growth conditions ( Figures 1R,  1U , 1V, and S1Q). Rab5/EEA1-labeled vesicles were also enlarged and partially co-localized with LC3 puncta in hEPG5 KD cells ( Figures 1R, 1X , and S1Q). EEA1 puncta were separable from LAMP1-labeled late endosomes/lysosomes in control cells, while a few enlarged EEA1 puncta were LAMP1 positive in hEPG5 KD cells (Figures S1O, S1R, and S1S). The enlarged LC3 and Rab5 puncta, however, were not stained by lysotracker, indicating that they are not acidic ( Figures S1T and S1U) . In control cells, EHD1-labeled recycling endosomes formed tubular structures and a few punctate structures that were separable from LC3 puncta ( Figures 1S and 1X ). In hEPG5 KD cells, tubular EHD1-labeled recycling endosomes were reduced, and there was dramatic accumulation of spherical structures that co-localized with LC3 puncta (Figures 1T and 1X ). These results are consistent with the idea that epg-5/hEPG5 is required for specific fusion of autophagosomes with endocytic vesicles.
hEPG5 Localizes on Late Endosomes/Lysosomes
In addition to having a diffuse cytoplasmic localization, GFPhEPG5 formed distinct puncta, mostly in the perinuclear region ( Figure 2A ). Staining with endogenous proteins or co-expression with reporters for endocytic vesicle markers revealed that GFPhEPG5 co-localized primarily with Rab7-and Rab9-labeled late endosomes ( Figures 2A, 2I , S3A, and S3B). Expression of GFPhEPG5 did not change the distribution, morphology, and size of late endosomes/lysosomes (Figures 2A and S3A ). Some small GFP-hEPG5 puncta, located mainly in the peripheral region, were negative for RFP-Rab7 (Figures 2A and S3A ). Structured illumination microscopy (SIM) revealed that hEPG5 overlapped with Rab7 on vesicular membranes ( Figure 2B ). GFP-hEPG5 also co-localized with LAMP1-labeled late endosomes/lysosomes ( Figures 2C, 2I , S3C, and S4J). Most GFP-hEPG5 puncta co-localized with lysotracker-stained acidic vesicles (Figures 2D, 2I, and S3D). Some hEPG5 +
Rab7
+ vesicles were lysotracker negative ( Figures 2E and 2J ). GFP-hEPG5 puncta were largely distinct from Rab5/EEA1/2xFYVE-labeled early endosomes and EHD1/TfnR-labeled recycling endosomes (Figures 2F, 2I, .
Immunogold electron microscopy analysis of cells transfected with GFP-hEPG5 revealed that gold particles recognizing GFPhEPG5 were localized on the membranes of organelles that resembled late endosomes and hybrid organelles resulting from endosome/lysosome fusion (Figures 2G, 2H, . Together, these results show that hEPG5 is mainly localized on late endosomes/lysosomes.
EPG5 Directly Binds to Rab7
The subcellular localization of EPG5 prompted us to investigate whether EPG5 interacts with Rab7 on late endosomes/lysosomes. Recombinant full-length (FL) worm EPG-5 bound strongly to RAB-7 in an in vitro pull-down assay, while neither RAB-5 nor RAB-11, which localize on early and sorting endosomes, respectively, showed strong binding to . EPG-5 bound to the constitutively active RAB-7(Q68L) mutant (GTP locked form, corresponding to Q67L in human Rab7), but not the dominant inhibitory RAB-7(T23N) mutant (GDP locked form, corresponding to T22N in human Rab7) ( Figure 3B ). An EPG-5 fragment containing amino acids 1-760, EPG-5(1-760), but not EPG-5(691-1,599), bound to RAB-7 in a pull-down assay ( Figures S4A and S4B ). The minimal RAB-7-binding region was delineated to EPG-5(500-530) ( Figure S4C ). Flag::EPG-5 was specifically co-precipitated by GFP::RAB-7 in a GFP-TRAP assay (a co-immunoprecipitation [co-IP] assay, in which anti-GFP V H H is coupled to agarose beads for immunoprecipitation of GFP-fusion proteins) using extracts of worms expressing Flag::EPG-5 and GFP::RAB-7 ( Figure S4D ). Endogenous hEPG5 was precipitated by endogenous Rab7 in a co-IP assay ( Figure 3C ). GFP-hEPG5 also immunoprecipitated endogenous Rab7 in GFP-TRAP assays ( Figure 3D ). Endogenous hEPG5 was precipitated by WT Rab7 and GFPRab7(Q67L), but not by GFP-Rab7(T22N) ( Figure 3E ). Levels of Rab7(Q67L) precipitated by hEPG5 were much higher than Rab7(T22N) ( Figure S4E ). hEPG5(427-1094) bound to Rab7 in in vitro pull-down assays ( Figure 3F ). hEPG5(546-599), covering the minimal RAB-7-binding region in worm EPG-5, bound strongly to Rab7 ( Figures 3G, S4F , and S4G). Rab7 was not precipitated by hEPG5 with a deletion of amino acids 546-575, hEPG5(del 546-575), in a co-IP assay ( Figure 3D ).
Localization of hEPG5 to Late Endosomes/Lysosomes Depends on Rab7
We next investigated whether hEPG5 is recruited to late endosomes/lysosomes by Rab7. Co-transfection of Rab7(Q67L) resulted in formation of enlarged perinuclear GFP-hEPG5 vesicles that co-localized with Rab7 ( Figure 3H ). In cells co-expressing Rab7(T22N), or treated with Rab7 small interfering RNA (siRNA), the diffuse GFP-hEPG5 signal was stronger ( Figures 3I, S4H , and S4K). A few small cytoplasmic GFP-hEPG5 puncta co-localized with LAMP1-labeled vesicles ( Figures S4J and S4K ). The pattern of WT and mutant Rab7 was unchanged by co-expression of GFP-hEPG5 ( Figures 3H, 3I , S3A, and S4I).
To examine whether hEPG5 is dynamically associated with late endosomes/lysosomes, we performed fluorescence recovery after photobleaching (FRAP) experiments in HeLa cells expressing GFP-hEPG5. The fluorescence signal from GFPhEPG5-labeled vesicles recovered 5 s after photobleaching in cells co-expressing Rab7 or Rab7(Q67L) (Figures S4L and S4M) , but reappeared much more slowly in cells co-expressing Rab7(T22N) ( Figure S4N ), suggesting that hEPG5 is dynamically recruited to late endosomes/lysosomes by Rab7.
hEPG5 Localizes with Amphisomes/Autolysosomes upon Autophagy Induction We next examined the localization of hEPG5 under autophagy induction conditions. hEPG5 was distinct from IMs labeled by WIPI2, ATG16L-GFP, and DFCP1-GFP ( Figures 4A, S5A-S5C , and S5U). GFP-hEPG5 puncta partially co-localized with LC3 after starvation (Figures 4B, 4E, . SIM revealed that LC3 signals were present inside, present on the surface of, or closely associated with GFP-hEPG5-positive vesicles ( Figure 4C ). The stage of the autophagic structures that co-localized with hEPG5 was further determined. STX17 is reported to be present on closed autophagosomes (Itakura et al., 2012 ) are acidified mature autophagosomes (likely amphisomes) as well as autolysosomes. Both yellow and red LC3 puncta co-localized with hEPG5 after starvation ( Figures 4H and S5J ), indicating that acidification is not required for co-localization of autophagosomes with hEPG5 vesicles. Co-localization of LC3 with hEPG5 puncta may result from translocation of hEPG5 to autophagosomes or fusion of autophagosomes with hEPG5-labeled late endosomes/lysosomes. Translocation of hEPG5 to autophagosomes would result in accumulation of autophagosomes labeled by LC3 and GFP-hEPG5, but not by LAMP1. Most LC3 + hEPG5 + puncta were positive for LAMP1 after starvation ( Figures 4I and 4J ). Colocalization of GFP-hEPG5 with LC3 puncta was decreased after RNAi KD of STX17 or SNAP29 ( Figures 4D, 4E , S5H, S5S, and S5T). These results suggested that hEPG5 is not recruited to autophagosomes before fusion with late endosomes/lysosomes.
EPG5 Binds to LGG-1/LC3
The above results suggest that EPG5 participates in autophagosome maturation. We investigated whether hEPG5 directly interacts with LC3. Co-IP assays revealed that Myc-hEPG5 specifically precipitated endogenous LC3, and endogenous LC3 precipitated endogenous hEPG5 (Figures 4K and 4L) . In in vitro pull-down assays, hEPG5(427-1,094) bound to LC3, and the interacting region was further delineated to hEPG5(546-575) (Figures 4M and S5V) . hEPG5(del 546-575) did not immunoprecipitate LC3 in co-IP assays ( Figure 4N ). Flag::EPG-5 was specifically immunoprecipitated by GFP::
LGG-1 from worm extracts in GFP-TRAP assays ( Figure S5W ). Recombinant FL EPG-5 interacted strongly with LGG-1 in a pull-down assay ( Figure 4O ). EPG-5(500-530), which corresponds to hEPG5(546-575), also bound strongly to LGG-1, while EPG-5(del 500-530) did not bind to LGG-1 ( Figures 4P and 5C ). Figure 5A ). In in vitro pull-down and co-IP assays, LC3 binding to hEPG5(427-1094) and FL hEPG5 was reduced by the W550A or W567A mutation, and abolished by the W550 W567 double mutation ( Figures 5B and S5X) . EPG-5(500-530) contains two typical LIR motifs, 507 WEIL and 523 FVTI ( Figures  5A, S5Y , and S5Z). EPG-5(W507A) and EPG-5(F523A) impaired, while EPG-5(W507A F523A) dramatically reduced, LGG-1 binding ( Figure 5C ). EPG-5(500-530) binds to LGG-1 as well as RAB-7. EPG-5(del 500-530) did not bind to RAB-7 ( Figure 5D ). Binding of RAB-7 to EPG-5(F523A) was reduced, while binding to EPG-5(W507A) and EPG-5(W507A F523A) was even more severely affected (Figure 5D) . The hydrophobic residue (I/L/V) at the ''+3'' position in LIR motifs is also involved in LC3/LGG-1 binding (Wu et al., 2015) . L510A mutation also impaired interactions of EPG-5 with LGG-1 and RAB-7 ( Figure S5A1 ), suggesting that the EPG-5 LIR motif is involved in RAB-7 binding. The two corresponding aromatic amino acids in hEPG5(546-575) are also important for mediating (E-H) Localization of GFP-hEPG5 mutants in HeLa cells co-transfected with RFP-Rab7(Q67L). GFP-hEPG5(del 546-575) (E), GFP-hEPG5(W550A W567A) (F), and GFP-hEPG5(W567A) (H) are mainly diffuse in the cytoplasm, while GFP-hEPG5(W550A) (G) forms some small puncta. (I-L) LGG-1 puncta, detected by anti-LGG-1, are absent in WT embryos at the 4-fold stage (I and J), but dramatically accumulate in epg-5 mutant embryos at the same stage (K and L). (M-T) Accumulation of LGG-1 puncta in epg-5 mutant embryos is rescued by a transgene expressing WT EPG-5 (N), but not mutant EPG-5(del 500-530) (P) or EPG-5(W507A) (R). The EPG-5(F523A) transgene partially rescues the defect in epg-5 mutants (T). (I), (K), (M), (O), (Q), and (S) show DAPI images of the embryos in (J), (L), (N), (P), (R), and (T), respectively. Scale bars, 10 and 2 mm (inserts). The size of C. elegans embryos remains constant, so the scale bar is only shown once. the hEPG5/Rab7 interaction. In co-IP assays, binding to Rab7 was almost abolished by hEPG5(W550A W567A) and was impaired by hEPG5(W550A) and hEPG5(W567A) ( Figure S5X ). Consistent with the critical role of amino acids 546-575 and the two aromatic residues W550 and W567 in hEPG5 binding to Rab7, GFP-hEPG5(del 546-575), GFP-hEPG5(W567A), and GFP-hEPG5(W550A W567A) were diffusely localized in the cytoplasm, while GFP-hEPG5(W550A) was largely diffuse apart from a few small puncta (Figures 5E-5H) .
We next performed rescue experiments to examine whether binding of EPG-5 to LGG-1/RAB-7 is critical for EPG-5 function.
LGG-1 puncta are present in early C. elegans embryos, but are largely absent in late embryos from the comma stage onward ( Figures 5I and 5J) (Tian et al., 2010) . LGG-1 puncta accumulate and persist in late epg-5 embryos ( Figures 5K and 5L) (Tian et al., 2010) . The autophagy substrate SQST-1::GFP also greatly accumulates in epg-5 mutants ( Figures S5K-S5N ) (Tian et al., 2010) . Accumulation of LGG-1 puncta and SQST-1 aggregates in epg-5 mutant embryos was rescued by a transgene expressing WT EPG-5 ( Figures 5M, 5N , and S5O), but not EPG-5(del 500-530) or EPG-5(W507A) ( Figures 5O-5R , S5P, and S5Q). EPG-5(F523A) retained partial rescuing activity ( Figures 5S, 5T , and S5R). W507 and F523 in EPG-5 are essential for binding to RAB-7 and LGG-1. These results suggest that binding to LGG-1 and/or RAB-7 is essential for the role of epg-5 in autophagy.
EPG5 Binds to STX17-SNAP29 Qabc and Also to the STX17-SNAP29-VAMP8 QabcR SNARE Complex FL worm SNAP-29, STX-17, and VAMP-7, or the corresponding SNARE domains, assembled into 1:1:1 complexes in an in vitro co-purification experiment ( Figures S6A-S6C ). Flag::SNAP-29 was co-immunoprecipitated by GFP::STX-17 and GFP::VAMP-7 from worm extracts in co-IP assays ( Figures S6D and S6E ). Flag::EPG-5 was specifically co-precipitated by GFP::STX-17 and GFP::VAMP-7 in GFP-TRAP assays of extracts from animals expressing tagged EPG-5 and SNARE proteins (Figures S6F and S6G) . We further investigated whether EPG-5 interacts with individual Syntaxins and/or with pre-assembled SNARE complexes in in vitro pull-down assays. FL recombinant EPG-5 bound very weakly to STX-17, SNAP-29, or VAMP-7 ( Figure 6A ). However, EPG-5 bound strongly with STX-17-SNAP-29 Qabc complexes and also with pre-assembled STX-17-SNAP-29-VAMP-7 QabcR complexes ( Figures 6B and 6C ). Pre-assembled SNARE domains of STX-17-SNAP-29 and STX-17-SNAP-29-VAMP-7 also bound strongly to FL EPG-5 and EPG-5(375-696) ( Figures  6D, 6E , and S6H). EPG-5(del 500-530) and EPG-5(W507A W523A), which impaired RAB-7 and LGG-1 binding, still bound strongly to STX-17-SNAP-29-VAMP-7 complexes ( Figure S6I ).
Endogenous STX17 was co-immunoprecipitated by endogenous hEPG5 using starved HeLa cell extracts ( Figure 6F ). GFPhEPG5 also immunoprecipitated endogenous STX17, SNAP29, and VAMP8 in GFP-TRAP assays ( Figures 6G and S6J) . The late endosomal/lysosomal R-SNARE VAMP7, which interacts with STX17, is also involved in formation and maturation of autophagosomes (Itakura et al., 2012; Lamb et al., 2013) . hEPG5 immunoprecipitated endogenous VAMP7 ( Figure 6G ). Endogenous hEPG5 was also co-immunoprecipitated by GFP-VAMP7 and GFP-VAMP8 (Figures 6H and S6K) . No interaction between endogenous hEPG5 and STX5-GFP or STX10-GFP was detected in co-IP assays ( Figures S6L and S6M ). hEPG5(del 546-575) and hEPG5(W550A W567A) still immunoprecipitated endogenous STX17, SNAP29, and VAMP8 ( Figures S6J and  S6N) . In vitro pull-down assays showed that hEPG5(427-1094) bound very weakly to STX17, SNAP29, and VAMP7/8 (Figure S6O) . However, hEPG5(427-1094) bound strongly to preassembled STX17-SNAP29 and STX17-SNAP29-VAMP8 complexes ( Figures 6I and 6J ). hEPG5(427-1094) also bound to pre-assembled SNARE domains of STX17-SNAP29-VAMP7/8 ( Figures S6P and S6Q) . Together, these results suggest that EPG-5/hEPG5 binds to assembled Qabc and QabcR SNARE complexes that are required for fusion of autophagosomes with late endosomes/lysosomes. VAMP8 and VAMP7 localize on late endosomes/lysosomes ( Figures 6K and S6R ). GFP-VAMP7 also formed some puncta at the cell periphery ( Figure S6R ). hEPG5 puncta co-localized extensively with VAMP8 and VAMP7 ( Figures 6K and S6R) . Mutant VAMP7/8 lacking the membrane-anchoring motif localized mainly to the peripheral cytoplasm and the plasma membrane ( Figures 6L and S6S ). In cells expressing mutant VAMP7/8, the diffuse cytoplasmic GFP-hEPG5 signal was stronger, and the dispersed GFP-hEPG5 puncta were smaller and fewer ( Figures 6L and S6S) , suggesting that the interaction with VAMP7/8 contributes to the retention of hEPG5 on late endosomes/lysosomes.
hEPG5 Promotes the Assembly of STX17-SNAP29-VAMP8 Complexes Levels of endogenous STX17, SNAP29, and VAMP7/8 were much lower in hEPG5 KD cells than controls ( Figure 6M ), indicating that hEPG5 stabilizes STX17, SNAP29, and VAMP7/8. The formation of STX17-SNAP29-VAMP8 SNARE complexes was also examined in hEPG5 KD cells. Levels of endogenous SNAP29 co-immunoprecipitated by STX17 did not change in hEPG5 KD cells (levels of precipitated SNAP29 were normalized to the corresponding STX17 in control and hEPG5 KD cells, respectively) ( Figure 6N ). However, much less endogenous VAMP8 and VAMP7 was precipitated by endogenous STX17 in hEPG5 KD cells (Figures 6O and S6T) . Thus, hEPG5 promotes and/or stabilizes the STX17-SNAP29-VAMP8 trans-SNARE complex.
We next determined whether hEPG5 regulates the assembly of SNARE complexes in vitro. STX17, SNAP29, and VAMP8 were incubated with or without hEPG5(427-1094), and the assembled complexes were monitored by SDS-PAGE. The assembled SNARE complex is resistant to SDS but sensitive to heat treatment. Levels of assembled SNARE complexes were increased about 4-fold in the presence of hEPG5 ( Figures 6P and 6Q ), indicating that hEPG5 facilitates trans-SNARE assembly.
EPG-5 Promotes Tethering and Lipid Mixing of Proteoliposomes Mediated by STX-17-SNAP-29-VAMP-7
To test whether EPG-5 directly facilitates SNARE-mediated tethering and fusion, we performed classic in vitro lipid mixing assays using purified components. STX-17 and SNAP-29 were reconstituted into vesicles containing the fluorophore NBD and (legend continued on next page) rhodamine-labeled phospholipids (donor vesicles), whereas VAMP-7 was reconstituted with unlabeled lipids (acceptor vesicles). The concentrations of NBD and rhodamine-conjugated lipids are high enough in the donor vesicles that the fluorescence of NBD is quenched by rhodamine. Once fusion with acceptor vesicles occurs, the labeled lipids become diluted, resulting in NBD fluorescence ( Figure 6R ). Consistent with previous reports, the presence of SNAREs alone caused little vesicle fusion ( Figure 6S ). In the presence of purified GST-EPG-5, but not GST alone, SNARE-mediated fusion was increased 2-fold ( Figures 6S, S6U , and S6V; data not shown). Fusion was not detected when SNAP-29 was absent ( Figure 6S ). Thus, EPG-5 promotes lipid mixing that is mediated by STX-17-SNAP-29-VAMP-7.
To further test whether RAB-7 plays a role in recruiting EPG-5 to membranes, we anchored RAB-7 onto vesicles by adding the transmembrane domain (TMD) of Sec61b to its C terminus, and monitored membrane association of EPG-5 using a flotation assay. Indeed, some of EPG-5 protein floated to the top of the sucrose-density gradient when membrane-anchored, GTPgS-soaked RAB-7 was present in the vesicles ( Figure S6W ). Very little EPG-5 co-migrated with vesicles composed of lipids only ( Figure S6W ). Reconstituted, but not detergent-solubilized, RAB-7 was enriched in the top fractions, confirming the successful incorporation of TMD-containing RAB-7 into proteoliposomes ( Figure S6W ). Together, these results suggest that RAB-7 recruits EPG-5 to membranes when activated by GTP loading.
To test whether RAB-7-recruited EPG-5 can facilitate SNARE assembly and subsequent fusion, we co-reconstituted TMDcontaining RAB-7 and VAMP-7 into acceptor vesicles, and tested their fusion with STX-17-SNAP-29-containing donor vesicles ( Figure 6R ). RAB-7 alone does not promote fusion of SNARE-containing vesicles, but fusion was enhanced when EPG-5 was also present ( Figure 6S ). These results support the hypothesis that recruitment of EPG-5 by RAB-7, probably to late endosomal/lysosomal membranes, is essential for STX-17-SNAP-29-VAMP-7-mediated membrane fusion.
hEPG5 Depletion Increases the Formation of STX17-SNAP25-VAMP8 SNAREs
We investigated whether loss of hEPG5 activity affects formation of other SNARE complexes comprising STX17, SNAP29, or VAMP8. In control cells, the Qbc SNAP25-GFP is mainly localized to the plasma membrane and also to a few perinuclear puncta under normal growth conditions ( Figure 7A ). SNAP25-GFP puncta are distinct from STX17 ( Figures 7E and S7A) . In hEPG5 KD cells, SNAP25 formed numerous puncta under both normal and starved conditions ( Figures 7B and S7B ). SNAP25-GFP puncta were co-localized with STX17 and VAMP8 and also with LC3 puncta in hEPG5 KD cells ( Figures 7B-7E and S7B-S7F). SNAP25-GFP co-localized with EHD1-mCherrylabeled structures in control and hEPG5 KD cells ( Figures 7E,  S7G , and S7H). STX17 and VAMP8 did not non-selectively colocalize with SNARE proteins. STX17 puncta were separable from VAMP2-GFP-and VAMP4-GFP-labeled punctate structures, and VAMP8 was separable from GOSR2-GFP puncta in control and hEPG5 KD cells ( Figures S7I-S7N , S7Q, and S7R).
Since SNAP25 co-localizes with STX17 and VAMP8, we tested whether they form a complex. In co-IP assays, SNAP25-GFP interacted weakly with endogenous STX17 and VAMP8 in control cell extracts, while in hEPG5 KD cells, much more endogenous STX17 and VAMP8 was precipitated by SNAP25 ( Figure 7F ). Higher levels of endogenous SNAP25 were also co-immunoprecipitated by GFP-STX17 in hEPG5 KD cells ( Figure S7S ). Thus, hEPG5 depletion results in the assembly of STX17-SNAP25-VAMP8 SNARE complexes. Loss of hEPG5 activity does not non-selectively promote formation of SNARE complexes. Levels of endogenous VAMP8 co-precipitated by STX12-GFP or STX10-GFP remained unchanged in hEPG5 KD cells ( Figures  S7T and S7U) .
We next determined whether the increased formation of STX17-SNAP25-VAMP8 complexes contributes to the autophagic defect in hEPG5 KD cells. SNAP25 KD causes slight changes in levels of LC3 and p62 ( Figures 7G-7I ). Simultaneous KD of SNAP25 greatly reduced p62 and LC3 levels in hEPG5 KD cells (Figures 7G-7I) . The suppression effect caused by SNAP25 KD (F) Endogenous hEPG5 co-immunoprecipitates endogenous STX17 in a co-IP assay. Cells were starved for 2 hr and the resulting precipitants were immunoblotted with anti-STX17. (G) Endogenous STX17, SNAP29, VAMP8, and VAMP7 are precipitated by GFP-hEPG5 in GFP-TRAP assays. (H) Endogenous hEPG5 is precipitated by GFP-VAMP8 in a GFP-TRAP assay. (I and J) hEPG5(427-1094) binds strongly to assembled STX17-SNAP29 Qabc SNARE complexes (I) and assembled STX17-SNAP29-VAMP8 QabcR SNARE complexes (J). The assembled STX17 and VAMP8 lack the transmembrane region. (K) GFP-hEPG5 co-localizes extensively with Myc-VAMP8 puncta. (L) When co-expressed with the SNARE domain of Myc-VAMP8(1-73), which shows peripheral localization, GFP-hEPG5 is more diffuse and forms smaller, more dispersed puncta. (M) Endogenous STX17, SNAP29, VAMP8, and VAMP7 levels are much lower in hEPG5 KD cells in immunoblotting assays. STX17, SNAP29, VAMP8, and VAMP7 levels were set to 1 by normalizing with the corresponding actin input. (N) In a co-IP assay, similar levels of endogenous SNAP29 are precipitated by endogenous STX17 in hEPG5 KD and control cells. Cells were starved for 2 hr before analysis. Levels of co-immunoprecipitated SNAP29 were normalized to the corresponding STX17 (set to 1 in control cells).
(O) Levels of endogenous VAMP8 co-immunoprecipitated by STX17 are much lower in hEPG5 KD cells in a co-IP assay. Levels of co-precipitated VAMP8 were normalized to the corresponding STX17 (set to 1 in control cells). was inhibited by Baf.A1 treatment, which inhibits lysosomal degradation ( Figure 7I ). This indicates that SNAP25 KD promotes autophagic flux in hEPG5 KD cells. Co-localization of LC3 puncta with EHD1-positive structures in hEPG5 KD cells was also suppressed by simultaneous SNAP25 depletion (Figures 7J-7L ). EEA1 puncta were still enlarged in the double KD cells (Figures S7O and S7P) . Therefore, SNAP25 inactivation partially suppresses the autophagy defect caused by hEPG5 depletion.
DISCUSSION

EPG5 Is a Rab7 Effector that Mediates Autophagosome Maturation
Here we demonstrated that EPG5 determines the fusion specificity of autophagosomes with late endosomes/lysosomes (Figure 7M ). EPG5 is a Rab7 effector; it binds to the GTP-bound form of Rab7, but only weakly to the GDP-bound form. Recruitment of EPG5 to late endosomes/lysosomes is enhanced by a constitutively active mutant of Rab7, but is inhibited by a dominant-negative mutant. The membrane association of EPG5 is also regulated by its interaction with R-SNAREs VAMP7/8. Overexpression of mutant VAMP7/8 with a deletion of the membraneanchoring motif causes their mislocalization and also disrupts the late endosome/lysosome localization of EPG5. Multivalent interactions of EPG5 with Rab7 and VAMP7/8 may determine the spatial and temporal localization of EPG5 on microdomains of late endosomes/lysosomes. To mediate capturing, docking, and fusion of autophagosomes, EPG5 recognizes LC3/LGG-1 on the outer membrane of autophagosomes. EPG5 stabilizes and also facilitates the assembly of trans-SNARE complexes for autophagosome maturation. In hEPG5 KD cells, levels of STX17, SNAP29, and VAMP7/8, and the assembled STX17-SNAP29-VAMP8 SNARE complex, are dramatically reduced. EPG5 appears not to participate in the initial formation of the STX17-SNAP29 Qabc complex, and formation of this complex is unaffected in hEPG5 KD cells. EPG5 also accelerates trans-SNARE assembly. EPG5 binds simultaneously to STX17-SNAP29 Qabc-and VAMP7/8 R-SNAREs, and may serve as a platform to allow them to interact directly. VAMP7 and VAMP8 may function redundantly to mediate autophagosome maturation. Binding of EPG5 to the STX17-SNAP29 Qabc complex, but not individual STX17 and SNAP29, ensures that closed autophagosomes, but not IMs, are tethered and fused with late endosomes/lysosomes.
In mediating autophagosome maturation, EPG5 exhibits some properties of tethering factors involved in intracellular membrane trafficking. Most tethering factors are Rab effectors. Binding to Rabs and the SNARE complex contributes to their association with distinct membranes (Cai et al., 2007; Stenmark, 2009) . For example, the tethering factor p115 is initially recruited to COPII vesicles by Rab1, but is retained by interacting with COPII vesicle-associated SNAREs (Bentley et al., 2006) . Tethering factors also regulate SNARE stability. The Cog6 subunit of the COG complex interacts directly with and stabilizes Stx6 (Laufman et al., 2011) . Thus, EPG5 may act as a tethering factor to promote fusion of autophagosomes with late endosomes/lysosomes.
The concerted action of different tethering factors has been shown to ensure vesicle transport specificity (Brö cker et al., 2010; Yu and Hughson, 2010) . For example, interaction of p115 on COPII vesicles with the Golgi-resident GM130/ GRASP65 tethering complex is required for endoplasmic reticulum (ER)-to-Golgi vesicle transport (Shorter et al., 2002) . Autophagosomal HOPS and ATG14 have been shown to facilitate fusion of autophagosomes with late endosomes/lysosomes (Jiang et al., 2014; Diao et al., 2015) . Distinct from EPG5, ATG14 binds to STX17 and STX17-SNAP29 Qabc SNARE complexes on autophagosomes, but not to STX17-SNAP29-VAMP8 complexes (Diao et al., 2015) , indicating that ATG14 acts prior to the assembly of fusogenic SNAREs. EPG5 may act cooperatively with autophagosomal ATG14 and HOPS to tether and dock autophagosomes with late endosomes/lysosomes. Compared to loss of function of genes acting during autophagosome formation, the autophagy defect caused by EPG5 deficiency is weaker (Tian et al., 2010; Zhao et al., 2013a) , indicating that autophagic flux can progress at low levels in EPG5-depleted cells. ATG14 and the HOPS complex may mediate fusion of autophagosomes with late endosomes/lysosomes in EPG5-depleted cells. STX17-SNAP29-VAMP7/8 complexes may also be able to facilitate the slow progression of autophagic flux.
EPG5 Coordinates Endocytic Trafficking with Autophagosome Maturation
Autophagosome maturation involves fusion with early and late endosomes (Lamb et al., 2013) . The detailed itinerary for autophagosome maturation, however, remains largely unknown. Autophagosomes may intersect with endocytic vesicles at multiple points. Autophagosomes directly fuse with Rab7-positive endosomes/lysosomes, a process promoted by EPG5. Autophagosomes can also fuse with early endosomes to form amphisomes, (H) Real-time PCR analysis of siRNA KD efficiency. mRNA levels were normalized to that in control cells, which was set to 100. Data are shown as mean ± SEM (n = 3 independent experiments). *p < 0.05, ***p < 0.001. (I) Levels of LC3 and p62 in cells stably expressing control and hEPG5 shRNA transfected with control siRNA and SNAP25 siRNA with or without Baf.A1 treatment. p62 and LC3-II levels are normalized to the corresponding actin input (set to 1 in control cells). (J-L) EHD1-GFP puncta are separable from LC3 in SNAP25 KD cells (K). The enlarged EHD1-GFP puncta and co-localization of EHD1-GFP puncta with LC3 in hEPG5 KD cells are suppressed by simultaneous SNAP25 KD (L). (J) shows quantification of co-localization of EHD1-GFP puncta with LC3 puncta. Data are shown as mean ± SEM. *p < 0.05. (M) Model showing how EPG5 mediates fusion of autophagosomes with late endosomes/lysosomes. EPG5 is recruited to late endosomes/lysosomes by associating with Rab7 and VAMP7/8. EPG5 tethers late endosomes/lysosomes with autophagosomes by binding to LC3 and STX17/SNAP29 and facilitates the assembly of the trans-SNARE for fusion. Scale bars, 10 and 2 mm (inserts). See also Figure S7 . which gradually mature into late endosomes and then fuse with lysosomes. Whether EPG5 facilitates endosome maturation has yet to be determined.
Depletion of tethering factors impairs fusion of transport vesicles with their target membranes. Loss of TECPR1, HOPS, and ATG14 also causes accumulation of autophagosomes (Chen et al., 2012; Jiang et al., 2014; Diao et al., 2015) . However, Epg5 deficiency results in non-specific fusion of autophagosomes with various endocytic vesicles, leading to the formation of abnormally enlarged vesicles with mixed identities. These enlarged vesicles are not stained by lysotracker and thus are not degradative. Non-specific fusion of autophagosomes with EHD1-labeled recycling endosomes in hEPG5 depletion cells appears to be due to elevated formation of STX17-SNAP25-VAMP8 complexes. KD of SNAP25 partially suppresses the coalescence of autophagosomes with recycling endosomes and the autophagy defect in hEPG5-depleted cells. The abnormal assembly of SNARE complexes in hEPG5 KD cells may be caused by mislocalization or impaired stability of SNARE proteins as a result of abnormal fusion of autophagosomes with endocytic vesicles. Increased assembly of STX17-SNAP29-VAMP8 by reduced O-GlcNAc modification of SNAP29 also partially rescues the autophagy defect caused by EPG5 depletion (Guo et al., 2014) . In addition to autophagy, EPG5 is essential for endocytic recycling and endocytic degradation (Zhao et al., 2013a) . Consistent with this, hEPG5 forms small puncta that are not labeled by Rab7. The involvement of EPG5 in multiple intracellular trafficking processes suggests that EPG5 may coordinate autophagic and endocytic trafficking to maintain cellular homeostasis.
EPG5 and Pathogenesis of Vici Syndrome and ALS
Recessive mutations in human EPG5 cause Vici syndrome, a multisystem disorder with a wide range of clinical manifestations, including agenesis of the corpus callosum, myopathy, and combined immunodeficiency (Cullup et al., 2013) . Epg5-deficient mice share some phenotypes with Vici syndrome patients, including defective autophagy, neurodegeneration, and myopathy (Zhao et al., 2013b) . Epg5-deficient mice exhibit selective motor neuronal damage and recapitulate key features of amyotrophic lateral sclerosis (ALS) (Zhao et al., 2013a (Zhao et al., , 2013b . Non-degradative autophagic vacuoles accumulate in various tissues in Vici syndrome and Epg5 knockout mice, and this may contribute to the pathogenesis associated with EPG5 depletion. Our study provides insight into the molecular mechanisms underlying Vici syndrome and ALS.
EXPERIMENTAL PROCEDURES
Co-immunoprecipitation Assay HeLa cells stably expressing control short hairpin RNA (shRNA) or hEPG5 shRNA were transfected with control or hEPG5 siRNA for 72 hr. Forty-eight hours after siRNA transfection, cells were transfected with the indicated constructs for 24 hr. Cells were lysed in lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail). Lysates were centrifuged at 13,400 rpm and the supernatant (input) was collected and used for immunoprecipitation. For GFP-tag proteins, lysates were immunoprecipitated by GFP-TRAP agarose beads (ChromoTek, gta-20) for 1.5 hr at 4 C. For endogenous or other tagged proteins, lysates were incubated with diluted primary antibodies for 4 hr or overnight at 4 C, then with 25 mL pre-cleaned agarose beads for 1.5 hr. Precipitated immune complexes were washed five times with washing buffer and boiled for 10 min in 23 SDS-PAGE loading buffer for immunoblotting. Equal amount of extracts were used for treatment with control IgG and anti-Myc (or other indicated antibodies).
Assembly of C. elegans SNARE Complexes
The STX-17/SNAP-29/VAMP-7 complex was formed by mixing Trx-STX-17(1-199) (containing the cytosolic region), , , and GST-VAMP-7(167-233) (containing the SNARE domain of each protein) in a 2:2:1 molecular ratio. After incubating at 4 C overnight, the complex was conjugated to GST beads and washed extensively. Bound proteins were boiled in 53 SDS sample loading buffer and analyzed by SDS-PAGE and Coomassie blue staining. The STX-17-SNAP-29 complex was assembled in the same way except that GST-STX-17(1-199) and Trx-SNAP-29(31-245) were mixed in a 1:2 molecular ratio.
Data Analysis
All data are expressed as mean ± SEM. Immunoblot band density was quantified using ImageJ software (NIH Image). Unpaired t tests were used to analyze between-group differences. At least three independent repeats were performed for each experiment. 
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